reply reply 0 shares
HEARTio -Helping Clinicians Identify Cardiovascular Disease Faster
- ECGio is a stronger diagnostic tool that takes seconds to use, without the need for specialized training or workflow adjustments.
- For Clinicians: Superior diagnostic power without the need for radiation.
- For Clinicians: Non-disruptive to the traditional workflow that is simple to use.
- For Clinicians and Patients: Fraction of the cost of invasive testing for similar interpretation.
- For Payors: Fewer repeat admissions with better outpatient monitoring and highly specific to minimize serial testing.
- Today there is no one test for the determination of coronary artery disease at the point-of-care. We are looking to change that.
- HEARTio is bringing the power of AI to the first cardiovascular test in the diagnostic pathway, the electrocardiogram (ECG).
- HEARTio’s flagship product, ECGio, is an AI platform that brings the power of deep learning to a clinician’s fingertips.
- ECGio’s diagnostic power rivals that of further downstream testing in validation studies in predicting the presence, and severity of CAD.
- We use data from ECGs to develop deep learning algorithms focused on individualized predictions by identifying arterial stenosis.
- Healthcare Industry
- Medical insurance Industry
- Patients with heart disease and issues